Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Resting-state functional brain networks in first-episode psychosis: A 12-month follow-up study.

Ganella EP, Seguin C, Pantelis C, Whittle S, Baune BT, Olver J, Amminger GP, McGorry PD, Cropley V, Zalesky A, Bartholomeusz CF.

Aust N Z J Psychiatry. 2018 May 1:4867418775833. doi: 10.1177/0004867418775833. [Epub ahead of print]

PMID:
29806483
2.

Stress hormones and verbal memory in young people over the first 12 weeks of treatment for psychosis.

Allott KA, Yuen HP, Bartholomeusz CF, Rapado-Castro M, Phassouliotis C, Butselaar F, Wood SJ, Proffitt TM, Savage G, Phillips LJ, Bendall S, Markulev C, Reniers RLEP, Pantelis C, Baldwin L, McGorry PD, Garner B.

Psychiatry Res. 2018 Feb;260:60-66. doi: 10.1016/j.psychres.2017.11.044. Epub 2017 Nov 21.

PMID:
29175500
3.

Duration of untreated psychosis and neurocognitive functioning in first-episode psychosis: a systematic review and meta-analysis.

Allott K, Fraguas D, Bartholomeusz CF, Díaz-Caneja CM, Wannan C, Parrish EM, Amminger GP, Pantelis C, Arango C, McGorry PD, Rapado-Castro M.

Psychol Med. 2018 Jul;48(10):1592-1607. doi: 10.1017/S0033291717003002. Epub 2017 Nov 27.

PMID:
29173201
4.

Serotonin Analogues as Inhibitors of Breast Cancer Cell Growth.

Jose J, Tavares CDJ, Ebelt ND, Lodi A, Edupuganti R, Xie X, Devkota AK, Kaoud TS, Van Den Berg CL, Anslyn EV, Tiziani S, Bartholomeusz C, Dalby KN.

ACS Med Chem Lett. 2017 Sep 14;8(10):1072-1076. doi: 10.1021/acsmedchemlett.7b00282. eCollection 2017 Oct 12.

PMID:
29057053
5.

EGFR signaling promotes inflammation and cancer stem-like activity in inflammatory breast cancer.

Wang X, Reyes ME, Zhang D, Funakoshi Y, Trape AP, Gong Y, Kogawa T, Eckhardt BL, Masuda H, Pirman DA Jr, Yang P, Reuben JM, Woodward WA, Bartholomeusz C, Hortobagyi GN, Tripathy D, Ueno NT.

Oncotarget. 2017 Jul 4;8(40):67904-67917. doi: 10.18632/oncotarget.18958. eCollection 2017 Sep 15.

6.

MELK: a potential novel therapeutic target for TNBC and other aggressive malignancies.

Pitner MK, Taliaferro JM, Dalby KN, Bartholomeusz C.

Expert Opin Ther Targets. 2017 Sep;21(9):849-859. doi: 10.1080/14728222.2017.1363183. Epub 2017 Aug 16. Review.

PMID:
28764577
7.

Risk and resilience brain networks in treatment-resistant schizophrenia.

Ganella EP, Seguin C, Bartholomeusz CF, Whittle S, Bousman C, Wannan CMJ, Di Biase MA, Phassouliotis C, Everall I, Pantelis C, Zalesky A.

Schizophr Res. 2018 Mar;193:284-292. doi: 10.1016/j.schres.2017.07.014. Epub 2017 Jul 21.

PMID:
28735641
8.

Role of orbitofrontal sulcogyral pattern on lifetime cannabis use and depressive symptoms.

Chye Y, Solowij N, Ganella EP, Suo C, Yücel M, Batalla A, Cousijn J, Goudriaan AE, Martin-Santos R, Whittle S, Bartholomeusz CF, Lorenzetti V.

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):392-400. doi: 10.1016/j.pnpbp.2017.07.017. Epub 2017 Jul 20.

PMID:
28734940
9.

Ventricular volumes across stages of schizophrenia and other psychoses.

Berger GE, Bartholomeusz CF, Wood SJ, Ang A, Phillips LJ, Proffitt T, Brewer WJ, Smith DJ, Nelson B, Lin A, Borgwardt S, Velakoulis D, Yung AR, McGorry PD, Pantelis C.

Aust N Z J Psychiatry. 2017 Oct;51(10):1041-1051. doi: 10.1177/0004867417715914. Epub 2017 Jul 1.

PMID:
28670977
10.

Deterioration of visuospatial associative memory following a first psychotic episode: a long-term follow-up study.

Wannan CMJ, Bartholomeusz CF, Cropley VL, Van Rheenen TE, Panayiotou A, Brewer WJ, Proffitt TM, Henry L, Harris MG, Velakoulis D, McGorry P, Pantelis C, Wood SJ.

Psychol Med. 2018 Jan;48(1):132-141. doi: 10.1017/S003329171700157X. Epub 2017 Jun 19.

PMID:
28625185
11.

IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells.

Battula VL, Nguyen K, Sun J, Pitner MK, Yuan B, Bartholomeusz C, Hail N, Andreeff M.

Oncotarget. 2017 Jun 6;8(23):36936-36949. doi: 10.18632/oncotarget.16294.

12.

Discovery of a potent inhibitor of MELK that inhibits expression of the anti-apoptotic protein Mcl-1 and TNBC cell growth.

Edupuganti R, Taliaferro JM, Wang Q, Xie X, Cho EJ, Vidhu F, Ren P, Anslyn EV, Bartholomeusz C, Dalby KN.

Bioorg Med Chem. 2017 May 1;25(9):2609-2616. doi: 10.1016/j.bmc.2017.03.018. Epub 2017 Mar 10.

PMID:
28351607
13.

Functional brain networks in treatment-resistant schizophrenia.

Ganella EP, Bartholomeusz CF, Seguin C, Whittle S, Bousman C, Phassouliotis C, Everall I, Pantelis C, Zalesky A.

Schizophr Res. 2017 Jun;184:73-81. doi: 10.1016/j.schres.2016.12.008. Epub 2016 Dec 20.

PMID:
28011131
14.

c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun.

Xie X, Kaoud TS, Edupuganti R, Zhang T, Kogawa T, Zhao Y, Chauhan GB, Giannoukos DN, Qi Y, Tripathy D, Wang J, Gray NS, Dalby KN, Bartholomeusz C, Ueno NT.

Oncogene. 2017 May 4;36(18):2599-2608. doi: 10.1038/onc.2016.417. Epub 2016 Dec 12.

PMID:
27941886
15.

Deficits in social cognition in first episode psychosis: A review of the literature.

Healey KM, Bartholomeusz CF, Penn DL.

Clin Psychol Rev. 2016 Dec;50:108-137. doi: 10.1016/j.cpr.2016.10.001. Epub 2016 Oct 11. Review.

PMID:
27771557
16.

Structural neuroimaging across early-stage psychosis: Aberrations in neurobiological trajectories and implications for the staging model.

Bartholomeusz CF, Cropley VL, Wannan C, Di Biase M, McGorry PD, Pantelis C.

Aust N Z J Psychiatry. 2017 May;51(5):455-476. doi: 10.1177/0004867416670522. Epub 2016 Oct 12. Review.

PMID:
27733710
17.

White matter integrity in individuals at ultra-high risk for psychosis: a systematic review and discussion of the role of polyunsaturated fatty acids.

Vijayakumar N, Bartholomeusz C, Whitford T, Hermens DF, Nelson B, Rice S, Whittle S, Pantelis C, McGorry P, Schäfer MR, Amminger GP.

BMC Psychiatry. 2016 Aug 11;16(1):287. doi: 10.1186/s12888-016-0932-4. Review.

18.

Emotion recognition and theory of mind are related to gray matter volume of the prefrontal cortex in schizophrenia.

Maat A, van Haren NEM, Bartholomeusz CF, Kahn RS, Cahn W.

Eur Neuropsychopharmacol. 2016 Feb;26(2):255-264. doi: 10.1016/j.euroneuro.2015.12.013. Epub 2015 Dec 11.

PMID:
26711688
19.

Examining the association between social cognition and functioning in individuals at ultra-high risk for psychosis.

Cotter J, Bartholomeusz C, Papas A, Allott K, Nelson B, Yung AR, Thompson A.

Aust N Z J Psychiatry. 2017 Jan;51(1):83-92. doi: 10.1177/0004867415622691. Epub 2016 Jul 19.

PMID:
26698819
20.

Comprehensive Two- and Three-Dimensional RNAi Screening Identifies PI3K Inhibition as a Complement to MEK Inhibitor AS703026 for Combination Treatment of Triple-Negative Breast Cancer.

Lee J, Galloway R, Grandjean G, Jacob J, Humphries J, Bartholomeusz C, Goodstal S, Lim B, Bartholomeusz G, Ueno NT, Rao A.

J Cancer. 2015 Oct 28;6(12):1306-19. doi: 10.7150/jca.13266. eCollection 2015.

21.

Meta-analysis of Theory of Mind (ToM) impairment in bipolar disorder.

Bora E, Bartholomeusz C, Pantelis C.

Psychol Med. 2016 Jan;46(2):253-64. doi: 10.1017/S0033291715001993. Epub 2015 Oct 12. Review.

PMID:
26456502
22.

Antitumor Activity of KW-2450 against Triple-Negative Breast Cancer by Inhibiting Aurora A and B Kinases.

Kai K, Kondo K, Wang X, Xie X, Pitner MK, Reyes ME, Torres-Adorno AM, Masuda H, Hortobagyi GN, Bartholomeusz C, Saya H, Tripathy D, Sen S, Ueno NT.

Mol Cancer Ther. 2015 Dec;14(12):2687-99. doi: 10.1158/1535-7163.MCT-15-0096. Epub 2015 Oct 6.

23.

Investigation of orbitofrontal sulcogyral pattern in chronic schizophrenia.

Cropley VL, Bartholomeusz CF, Wu P, Wood SJ, Proffitt T, Brewer WJ, Desmond PM, Velakoulis D, Pantelis C.

Psychiatry Res. 2015 Nov 30;234(2):280-3. doi: 10.1016/j.pscychresns.2015.09.001. Epub 2015 Sep 5.

PMID:
26409572
24.

MEK Inhibitor Selumetinib (AZD6244; ARRY-142886) Prevents Lung Metastasis in a Triple-Negative Breast Cancer Xenograft Model.

Bartholomeusz C, Xie X, Pitner MK, Kondo K, Dadbin A, Lee J, Saso H, Smith PD, Dalby KN, Ueno NT.

Mol Cancer Ther. 2015 Dec;14(12):2773-81. doi: 10.1158/1535-7163.MCT-15-0243. Epub 2015 Sep 17.

25.

Effects of oxytocin and genetic variants on brain and behaviour: Implications for treatment in schizophrenia.

Bartholomeusz CF, Ganella EP, Labuschagne I, Bousman C, Pantelis C.

Schizophr Res. 2015 Nov;168(3):614-27. doi: 10.1016/j.schres.2015.06.007. Epub 2015 Jun 26. Review.

PMID:
26123171
26.

Baseline grey matter volume of non-transitioned "ultra high risk" for psychosis individuals with and without attenuated psychotic symptoms at long-term follow-up.

Cropley VL, Lin A, Nelson B, Reniers RLEP, Yung AR, Bartholomeusz CF, Klauser P, Velakoulis D, McGorry P, Wood SJ, Pantelis C.

Schizophr Res. 2016 Jun;173(3):152-158. doi: 10.1016/j.schres.2015.05.014. Epub 2015 May 29.

PMID:
26032566
27.

CD44 expression contributes to trastuzumab resistance in HER2-positive breast cancer cells.

Boulbes DR, Chauhan GB, Jin Q, Bartholomeusz C, Esteva FJ.

Breast Cancer Res Treat. 2015 Jun;151(3):501-13. doi: 10.1007/s10549-015-3414-3. Epub 2015 May 14.

PMID:
25971596
28.

Gender effects on brain changes in early-onset psychosis.

Rapado-Castro M, Bartholomeusz CF, Castro-Fornieles J, González-Pinto A, Otero S, Baeza I, Moreno C, Graell M, Janssen J, Bargalló N, Pantelis C, Desco M, Arango C.

Eur Child Adolesc Psychiatry. 2015 Oct;24(10):1193-205. doi: 10.1007/s00787-014-0669-x. Epub 2015 Jan 15.

PMID:
25589436
29.

Emotion recognition in unaffected first-degree relatives of individuals with first-episode schizophrenia.

Allott KA, Rice S, Bartholomeusz CF, Klier C, Schlögelhofer M, Schäfer MR, Amminger GP.

Schizophr Res. 2015 Feb;161(2-3):322-8. doi: 10.1016/j.schres.2014.12.010. Epub 2014 Dec 19.

PMID:
25533595
30.

Relationship between amygdala volume and emotion recognition in adolescents at ultra-high risk for psychosis.

Bartholomeusz CF, Whittle SL, Pilioussis E, Allott K, Rice S, Schäfer MR, Pantelis C, Amminger GP.

Psychiatry Res. 2014 Dec 30;224(3):159-67. doi: 10.1016/j.pscychresns.2014.10.005. Epub 2014 Oct 27.

PMID:
25456521
31.

HER family kinase domain mutations promote tumor progression and can predict response to treatment in human breast cancer.

Boulbes DR, Arold ST, Chauhan GB, Blachno KV, Deng N, Chang WC, Jin Q, Huang TH, Hsu JM, Brady SW, Bartholomeusz C, Ladbury JE, Stone S, Yu D, Hung MC, Esteva FJ.

Mol Oncol. 2015 Mar;9(3):586-600. doi: 10.1016/j.molonc.2014.10.011. Epub 2014 Nov 11.

32.

Abnormalities in orbitofrontal cortex gyrification and mental health outcomes in adolescents born extremely preterm and/or at an extremely low birth weight.

Ganella EP, Burnett A, Cheong J, Thompson D, Roberts G, Wood S, Lee K, Duff J, Anderson PJ, Pantelis C, Doyle LW, Bartholomeusz C; Victorian Infant Collaborative Study Group.

Hum Brain Mapp. 2015 Mar;36(3):1138-50. doi: 10.1002/hbm.22692. Epub 2014 Nov 19.

PMID:
25409629
33.

Development of PEA-15 using a potent non-viral vector for therapeutic application in breast cancer.

Xie X, Tang H, Pengliu, Kong Y, Wu M, Xiao X, Yang L, Gao J, Wei W, Lee J, Bartholomeusz C, Ueno NT, Xie X.

Cancer Lett. 2015 Jan 28;356(2 Pt B):374-381. doi: 10.1016/j.canlet.2014.09.033. Epub 2014 Oct 7.

34.

Relationship between membrane fatty acids and cognitive symptoms and information processing in individuals at ultra-high risk for psychosis.

Kim SW, Schäfer MR, Klier CM, Berk M, Rice S, Allott K, Bartholomeusz CF, Whittle SL, Pilioussis E, Pantelis C, McGorry PD, Amminger GP.

Schizophr Res. 2014 Sep;158(1-3):39-44. doi: 10.1016/j.schres.2014.06.032. Epub 2014 Jul 25.

PMID:
25066495
35.

A class I histone deacetylase inhibitor, entinostat, enhances lapatinib efficacy in HER2-overexpressing breast cancer cells through FOXO3-mediated Bim1 expression.

Lee J, Bartholomeusz C, Mansour O, Humphries J, Hortobagyi GN, Ordentlich P, Ueno NT.

Breast Cancer Res Treat. 2014 Jul;146(2):259-72. doi: 10.1007/s10549-014-3014-7. Epub 2014 Jun 12.

36.

Social neuroscience in psychiatry: pathways to discovering neurobiological risk and resilience.

Pantelis C, Bartholomeusz CF.

World Psychiatry. 2014 Jun;13(2):146-7. doi: 10.1002/wps.20123. No abstract available.

37.

Antagonism of tumoral prolactin receptor promotes autophagy-related cell death.

Wen Y, Zand B, Ozpolat B, Szczepanski MJ, Lu C, Yuca E, Carroll AR, Alpay N, Bartholomeusz C, Tekedereli I, Kang Y, Rupaimoole R, Pecot CV, Dalton HJ, Hernandez A, Lokshin A, Lutgendorf SK, Liu J, Hittelman WN, Chen WY, Lopez-Berestein G, Szajnik M, Ueno NT, Coleman RL, Sood AK.

Cell Rep. 2014 Apr 24;7(2):488-500. doi: 10.1016/j.celrep.2014.03.009. Epub 2014 Apr 3.

38.

Emotion recognition as a predictor of transition to a psychotic disorder in ultra-high risk participants.

Allott KA, Schäfer MR, Thompson A, Nelson B, Bendall S, Bartholomeusz CF, Yuen HP, McGorry PD, Schlögelhofer M, Bechdolf A, Amminger GP.

Schizophr Res. 2014 Mar;153(1-3):25-31. doi: 10.1016/j.schres.2014.01.037. Epub 2014 Feb 16.

PMID:
24552619
39.

Bisphosphorylated PEA-15 sensitizes ovarian cancer cells to paclitaxel by impairing the microtubule-destabilizing effect of SCLIP.

Xie X, Bartholomeusz C, Ahmed AA, Kazansky A, Diao L, Baggerly KA, Hortobagyi GN, Ueno NT.

Mol Cancer Ther. 2013 Jun;12(6):1099-111. doi: 10.1158/1535-7163.MCT-12-0737. Epub 2013 Mar 29.

40.

Sulcogyral patterns and morphological abnormalities of the orbitofrontal cortex in psychosis.

Bartholomeusz CF, Whittle SL, Montague A, Ansell B, McGorry PD, Velakoulis D, Pantelis C, Wood SJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jul 1;44:168-77. doi: 10.1016/j.pnpbp.2013.02.010. Epub 2013 Feb 26.

PMID:
23485592
41.

Social cognition training as an intervention for improving functional outcome in first-episode psychosis: a feasibility study.

Bartholomeusz CF, Allott K, Killackey E, Liu P, Wood SJ, Thompson A.

Early Interv Psychiatry. 2013 Nov;7(4):421-6. doi: 10.1111/eip.12036. Epub 2013 Feb 28.

PMID:
23445268
42.

Ink4a/Arf(-/-) and HRAS(G12V) transform mouse mammary cells into triple-negative breast cancer containing tumorigenic CD49f(-) quiescent cells.

Kai K, Iwamoto T, Kobayashi T, Arima Y, Takamoto Y, Ohnishi N, Bartholomeusz C, Horii R, Akiyama F, Hortobagyi GN, Pusztai L, Saya H, Ueno NT.

Oncogene. 2014 Jan 23;33(4):440-8. doi: 10.1038/onc.2012.609. Epub 2013 Feb 4.

43.

Externalized attributional bias in the Ultra High Risk (UHR) for psychosis population.

Thompson A, Papas A, Bartholomeusz C, Nelson B, Yung A.

Psychiatry Res. 2013 Apr 30;206(2-3):200-5. doi: 10.1016/j.psychres.2012.10.017. Epub 2012 Nov 21.

PMID:
23177592
44.

Orbitofrontal sulcogyral patterns are related to temperamental risk for psychopathology.

Whittle S, Bartholomeusz C, Yücel M, Dennison M, Vijayakumar N, Allen NB.

Soc Cogn Affect Neurosci. 2014 Feb;9(2):232-9. doi: 10.1093/scan/nss126. Epub 2012 Nov 18.

45.

Role of epidermal growth factor receptor in breast cancer.

Masuda H, Zhang D, Bartholomeusz C, Doihara H, Hortobagyi GN, Ueno NT.

Breast Cancer Res Treat. 2012 Nov;136(2):331-45. doi: 10.1007/s10549-012-2289-9. Epub 2012 Oct 17. Review.

46.

Neurocognitive and social cognitive approaches for improving functional outcome in early psychosis: theoretical considerations and current state of evidence.

Bartholomeusz CF, Allott K.

Schizophr Res Treatment. 2012;2012:815315. doi: 10.1155/2012/815315. Epub 2012 Apr 5.

47.

Social cognition in clinical "at risk" for psychosis and first episode psychosis populations.

Thompson A, Papas A, Bartholomeusz C, Allott K, Amminger GP, Nelson B, Wood S, Yung A.

Schizophr Res. 2012 Nov;141(2-3):204-9. doi: 10.1016/j.schres.2012.08.007. Epub 2012 Sep 5.

PMID:
22959742
48.

High ERK protein expression levels correlate with shorter survival in triple-negative breast cancer patients.

Bartholomeusz C, Gonzalez-Angulo AM, Liu P, Hayashi N, Lluch A, Ferrer-Lozano J, Hortobágyi GN.

Oncologist. 2012;17(6):766-74. doi: 10.1634/theoncologist.2011-0377. Epub 2012 May 14.

49.

Targeting the PI3K signaling pathway in cancer therapy.

Bartholomeusz C, Gonzalez-Angulo AM.

Expert Opin Ther Targets. 2012 Jan;16(1):121-30. doi: 10.1517/14728222.2011.644788. Epub 2012 Jan 12. Review.

PMID:
22239433
50.

PEA-15 unphosphorylated at both serine 104 and serine 116 inhibits ovarian cancer cell tumorigenicity and progression through blocking β-catenin.

Lee J, Bartholomeusz C, Krishnamurthy S, Liu P, Saso H, Lafortune TA, Hortobagyi GN, Ueno NT.

Oncogenesis. 2012 Jul 16;1:e22. doi: 10.1038/oncsis.2012.22.

Supplemental Content

Loading ...
Support Center